glp 1 compounds Discovery of compound 19, a potent positive allosteric modulators of the glucagon-like peptide-1 receptor (GLP-1R) Why the FDA is cracking
Description
Of those, 4 RCTs [1, 2, 4] as SURMONT-OSA Trial by Malhotra et al
Our previous work has shown that GLP-1 RAs make up 5% of prescriptions within the US (although this trend has increased, as seen in the latest GLP-1 prescribing and dispense report)
Circulation 145 , 575585 (2022) H.C
The Medicare GLP-1 Bridge will provide coverage of three GLP-1s (Wegovy, Zepbound, and Foundayo) that have been approved by the FDA for chronic weight management in adults with obesity (BMI of 30 or more) or adults with overweight (BMI of 27 or more) plus a weight-related comorbid condition
Initially, researchers developed drugs with GLP-1s to treat diabetes, but quickly observed that the drug led to significant weight loss
